Keywords: German pharma, VFA, antibiotics, MRSA,

German Pharma overcoming resistant bacteria

Article | 26 November 2009

"Bacteria that are resistant to antibiotics are becoming ever more widespread", says Cornelia Yzer, general manager of the VFA (the German Pharmaceutical Industry Association), in a statement to mark European Antibiotic Awareness Day, an initiative by the European Centre for Disease Prevention and Control. "Pharma firms are therefore working hard to provide the German market with new antibiotics to tackle resistant germs. They have already requested official approval for two, while six more are in the final phase of clinical trials."

A particular problem is MRSA (staphylococcus aureas), which is resistant to a wide range of drugs. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in